{
    "clinical_study": {
        "@rank": "161627", 
        "arm_group": [
            {
                "arm_group_label": "Transfusion trigger based on WCTS-CP", 
                "arm_group_type": "Experimental", 
                "description": "Determination of whether a patient need red blood cells transfusion or which hemoglobin level should be maintained is based on WCTS-CP"
            }, 
            {
                "arm_group_label": "Transfusion trigger based on experience", 
                "arm_group_type": "Active Comparator", 
                "description": "Determination of whether a patient need red blood cell transfusion or which hemoglobin level should be maintained is base on the physician's experience"
            }
        ], 
        "brief_summary": {
            "textblock": "Guidelines for blood transfusion have been issued for years. According to these guidelines,\n      red blood cells (RBCs) transfusion should be given when the hemoglobin level is less than\n      6g/dL or 7g/dL and is unnecessary when the level is more than 10g/dL. However, in all the\n      guidelines, the determination of whether RBCs should be administered when the hemoglobin\n      level is in the range of 6~10g/dL is based on the judgment from doctors. Index of\n      transfusion trigger for patients with hemoglobin level between 6g/dL and 10g/dL is necessary\n      and important in clinical practice.\n\n      Based on the aim of blood transfusion that maintain the balance of oxygen supply and oxygen\n      consumption, the investigators hypothesize that index of transfusion trigger for patients\n      with hemoglobin level between 6g/dL and 10g/dL could be calculated by parameters including\n      infusion rate of inotropic drugs for maintaining normal cardiac output, fraction of inspired\n      oxygen, core temperature, and torlerance to anemia. To verify this hypothesis, the\n      investigators present West China Transfusion Score for Critically-ill Patients(WCTS-CP) for\n      the trigger of transfusion according to the patient's history and monitoring parameters, and\n      the investigators design a randomized controlled clinical trial to test this score."
        }, 
        "brief_title": "West-China Transfusion Score for Critically-ill Patients", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Transfusion Related Complication", 
            "Critical Illness"
        ], 
        "condition_browse": {
            "mesh_term": "Critical Illness"
        }, 
        "detailed_description": {
            "textblock": "Anemia is a common phenomenon in critically ill patients, and blood transfusion may provide\n      guarantee for oxygen delivery. On the other hand, blood transfusion is associated with many\n      risks including hemolytic and nonhemolytic reactions, transfusion related acute lung injury\n      (TRALI), and others. Besides, blood is insufficient worldwide. How to eliminate allogeneic\n      blood transfusion is an important part in clinical practice.\n\n      Guidelines for blood transfusion have been issued for years. According to these guidelines,\n      red blood cells (RBCs) transfusion should be given when the hemoglobin level is less than\n      6g/dL or 7g/dL and is unnecessary when the level is more than 10g/dL. However, in all the\n      guidelines, the determination of whether RBCs should be administered when the hemoglobin\n      level is in the range of 6~10g/dL is based on the judgment from specific doctors. Index of\n      transfusion trigger for critically ill patients with hemoglobin level between 6g/dL and\n      10g/dL is necessary and important in clinical practice.\n\n      Based on the aim of blood transfusion that maintain the balance of oxygen supply and oxygen\n      consumption, the investigators hypothesize that index of transfusion trigger for patients\n      with hemoglobin level between 6g/dL and 10g/dL could be calculated by parameters including\n      infusion rate of inotropic drugs for maintaining normal cardiac output, fraction of inspired\n      oxygen for maintaining saturation of oxygen\u226795%, core temperature, and torlerance to anemia.\n\n      The investigators set down the West China Transfusion Score for Critically-ill\n      Patients(WCTS-CP) \uff0cthe initial score is 6. If a patient's cardiac output is normal without\n      infusion of inotropic drugs, the heartbeat less than 100 per minute\uff0chis saturation of oxygen\n      could be maintained more than 95%, his core temperature is less than 38\u2103, and he has no\n      history of ischemic cardiovascular disease , and he is below 55 of age\uff0chis score is 6.\n\n      If a patient has one or more problems, his score should be added 1 point for each problem.\n\n      The initial WCTS-CP score is 6, and the patient's score is calculated by the sum of each\n      item.\n\n      Score 6\uff1aThe transfusion trigger is 6g/dL, and the the patient's Hemoglobin level should be\n      maintained not less than 6g/dL.\n\n      Score 7\uff1aThe transfusion trigger is 7g/dL, and the the patient's Hemoglobin level should be\n      maintained not less than 7g/dL.\n\n      Score 8\uff1aThe transfusion trigger is 8g/dL, and the the patient's Hemoglobin level should be\n      maintained not less than 8g/dL.\n\n      Score 9\uff1aThe transfusion trigger is 9g/dL, and the the patient's Hemoglobin level should be\n      maintained not less than 9g/dL.\n\n      Score 10 or >10\uff1aThe transfusion trigger is 10g/dL, and the the patient's Hemoglobin level\n      should be maintained not less than 10g/dL."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Height of usual place of residence less than 2,500 metres above sea level\n\n          -  Hemoglobin level possibly less than 10g/dL\n\n        Exclusion Criteria:\n\n          -  Pregnant women\n\n          -  Age less than 18\n\n          -  Serious blood system diseases\n\n          -  Dysfunction of hemoglobin\n\n          -  Tumor metastasis\n\n          -  Psychopathy\n\n          -  Refuse to sign consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02139995", 
            "org_study_id": "Ethics-42"
        }, 
        "intervention": {
            "arm_group_label": [
                "Transfusion trigger based on WCTS-CP", 
                "Transfusion trigger based on experience"
            ], 
            "description": "transfusion trigger for experimental group is the WCTS-CP\uff1bfor active comparator is the physician's experience", 
            "intervention_name": "RBC transfusion based on different protocols", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "transfusion", 
            "trigger", 
            "critically-ill"
        ], 
        "lastchanged_date": "May 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chengdu", 
                    "country": "China", 
                    "state": "Sichuan", 
                    "zip": "610041"
                }, 
                "name": "West China Hospital"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "West-China Transfusion Score for Critically-ill Patients", 
        "overall_contact": {
            "last_name": "Jin Liu, M.D", 
            "phone": "18980601539"
        }, 
        "overall_contact_backup": {
            "email": "dengyiyun1@medmail.com.cn", 
            "last_name": "Yun yi Deng, M.D", 
            "phone": "18980602139"
        }, 
        "overall_official": {
            "affiliation": "West China Hospital", 
            "last_name": "Jin Liu, M.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Incidence of death and serious complications", 
            "safety_issue": "Yes", 
            "time_frame": "28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02139995"
        }, 
        "responsible_party": {
            "investigator_affiliation": "West China Hospital", 
            "investigator_full_name": "Yiyun Deng", 
            "investigator_title": "ICU", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Transfusion rate and transfusion volume of red blood cells", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }, 
            {
                "description": "The time that patients do not need ventilaton support", 
                "measure": "ventilator-free days in 28 days", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "length of stay in ICU or in hospital", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }
        ], 
        "source": "West China Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "West China Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}